Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 08, 2002 06:00 ET | Source: Novo Nordisk A/S

Status re Novo Nordisk's holding of its own shares

A total of 347,394 treasury shares were sold to Novo Nordisk employees in relation to a general employee share programme and a total of 37,500 options were exercised in the second quarter of...
May 21, 2002 06:00 ET | Source: Novo Nordisk A/S

by the members of the Board of Directors and the Executive Committee

The Novo Nordisk share and share option portfolios held by the members of the Board of Directors and the Executive Committee are listed in the following. For further information please visit our...
April 30, 2002 06:00 ET | Source: Novo Nordisk A/S

Financial statement for the first quarter of 2002

Compared to the first quarter of 2001, sales increased by 2% to DKK 5,481 million. The sales increase was 3% measured in local currencies. Diabetes care sales increased by 2% to...
April 10, 2002 06:00 ET | Source: Novo Nordisk A/S

First-quarter sales growth lower than expected - estimated full-year earnings growth reduced

These expectations exclude potential income related to the planned out-licensing of NN622 currently in Phase 3 development. The company is in the process of implementing a number of cost-containment...
April 05, 2002 05:00 ET | Source: Novo Nordisk A/S

Status re Novo Nordisk's holding of its own shares

Of the shares reserved for the employees at year-end 2001, 16,562 were not used and therefore returned to Novo Nordisk A/S. A total of 1,500 treasury shares were sold to Novo Nordisk employees in...
March 22, 2002 06:00 ET | Source: Novo Nordisk A/S

Novo Nordisk appoints Lise Kingo, head of Stakeholder Relations, member of the Executive Committee

Lars Rebien Sørensen says: "I am pleased to welcome Lise Kingo in ExComm. Her promotion is a testimony to the growing strategic importance of our focus on sustainable development and the Triple...
March 12, 2002 06:00 ET | Source: Novo Nordisk A/S

Annual General Meeting at Novo Nordisk A/S

At the Annual General Meeting of Novo Nordisk A/S today, the shareholders adopted - The Annual Financial Report including the Annual Accounts with Auditors' Report and Management Statement,...
February 28, 2002 06:00 ET | Source: Novo Nordisk A/S

Trading in Novo Nordisk securities by the members of the Board of Directors and the Executive Committee

The Novo Nordisk share and share option portfolios held by the members of the Board of Directors and the Executive Committee are listed in the following. For further information please visit our...
February 07, 2002 06:00 ET | Source: Novo Nordisk A/S

Novo Nordisk - Financial Results 2001

Novo Nordisk increased operating profit by 17% to DKK 5,614 million from DKK 4,816 million, thereby exceeding its 15% growth target. The growth was driven by a sales...
February 01, 2002 06:00 ET | Source: Novo Nordisk A/S

ZymoGenetics Inc announces an Initial Public Offering of Common Stock

As the 10,000,000 shares have been sold at USD 12 or at a 165% premium to the net book value/share prior to the offering, Novo Nordisk will record an accounting pretax income of approximately DKK...